ARB use was associated with a trend toward higher odds of progression (OR 1.52, 95% CI 0.97–2.37), although this did not reach statistical significance ( p = 0.06).
← all excerpts
Preliminary Findings of a Chronic Disease Management Program in Medicare Advantage Enrollees with Mild to Moderate Kidney Disease.
1
0.0600
0.0600